Maryland Capital Management’s Idexx Laboratories IDXX Stock Holding History

Maryland Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-400	Closed	-$219K	–	231
2022 Q1	$219K	Sell	400 -125	-24%	-$65.8K	0.01%	236
2021 Q4	$346K	Sell	525 -100	-16%	-$62.8K	0.02%	207
2021 Q3	$389K	Sell	625 -75	-11%	-$50.4K	0.02%	188
2021 Q2	$442K	Sell	700 -75	-10%	-$41.4K	0.03%	175
2021 Q1	$379K	Sell	775 -53	-6%	-$26.6K	0.03%	178
2020 Q4	$414K	Buy	828 +28	+4%	+$12.5K	0.03%	159
2020 Q3	$314K	Sell	800 -160	-17%	-$59.2K	0.03%	166
2020 Q2	$317K	Hold	960	–	–	0.03%	165
2020 Q1	$233K	Hold	960	–	–	0.03%	183
2019 Q4	$251K	Buy	960 +60	+7%	+$15.8K	0.03%	161
2019 Q3	$245K	Hold	900	–	–	0.03%	169
2019 Q2	$248K	Hold	900	–	–	0.03%	166
2019 Q1	$201K	Buy	+900	New	+$186K	0.02%	171
2018 Q4	–	Sell	-900	Closed	-$225K	–	176
2018 Q3	$225K	Buy	+900	New	+$218K	0.03%	157

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Maryland Capital Management's IDXX Position: Q2 2022 in Review

Maryland Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 400 shares — an estimated $219K sold.

Maryland Capital Management first reported a position in IDXX in Q3 2018 and held it in 14 quarters. The position peaked at $442K in Q2 2021. 957 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

Maryland Capital Management reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
Maryland Capital Management sold 400 Idexx Laboratories shares in Q2 2022, an estimated $219K.
Maryland Capital Management first reported a position in Idexx Laboratories in Q3 2018 and held it in 14 quarters.
Maryland Capital Management's Idexx Laboratories position peaked at $442K in Q2 2021.
957 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Maryland Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.